Oramed

ORMP NASDAQ
3.890
+0.350
+9.88%
交易中 14:57 07/17 EDT
开盘
3.540
昨收
3.540
最高
3.900
最低
3.460
成交量
8.88万
成交均量(3M)
4.21万
52周最高
5.91
52周最低
2.780
换手率
0.51%
市值
6,761.43万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Oramed ORMP股票价格,Oramed股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Oramed Pharmaceuticals Inc. (Oramed) is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed’s flagship product, an orally ingestible insulin capsule in phase II clinical trials, is focused on the treatment of diabetes. The Company is developing orally ingestible protein oral delivery (POD) technology for the delivery of drugs presently administered by way of injection. Oramed’s delivery platform protects protein sand enhances their absorption, allowing them to reach the blood stream through the portal vein. The Company’s products include ORMD-0801, Oral insulin capsule; ORMD 0901, Oral Exenatide capsule; and combination therapy of ORMD 0801 + ORMD 0901. ORMD-0801 is under phase II A clinical trials. ORMD-0901 is under preclinical/Investigational New Drug (IND) stage under phase I B.
展开 >

最近浏览

名称
价格
涨跌幅